Seven helix receptors are enzymes catalysing G protein activation. What is the agonist K(act)?

Journal of Theoretical Biology

Volumn 187, Issue 1, 1997, Pages 15-37

  Waelbroeck, Magali ^a   Boufrahi, Lamyae ^a   Swillens, Stéphane ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; LIGAND; PROTEIN SUBUNIT; RECEPTOR; RECEPTOR BLOCKING AGENT;

ARTICLE; BINDING KINETICS; ENZYME ACTIVITY; MODEL; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RECEPTOR AFFINITY; RECEPTOR BINDING;

EID: 0031558231     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1997.0411     Document Type: Article

References (39)

1. ABRAMSON, S. N., MCGONIGLE, P. & MOLINOFF, P. B. (1987). Evaluation of models for analysis of radioligand binding data. Mol. Pharmacol. 31, 103-111.
2. ASHKENAZI, A., WINSLOW, J. W., PERALTA, E. G., PETERSON, G. L., SCHIMERLIK, M. I., CAPON, D. J. & RAMACHANDRAN, J. (1987). An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science 238, 672-675.
3. BIRNBAUMER, L. & BIRNBAUMER, M. (1995). Signal transduction by G proteins. J. Recept. Sign. Transd. Res. 15, 213-252.
4. 2-adrenoceptor. Nature 374, 272-276.
5. BORNANCIN, F., PFISTER, C. & CHABRE, M. (1989). The transitory complex between photoexcited rhodopsin and transducin. Eur. J. Biochem. 184, 687-698.
6. BRUNS, R. F. (1996). Conformational induction versus conformational selection: evidence from allosteric enhancers. Trends. Pharmacol. Sci. 17, 189.
7. q. FEBS Lett. 363, 261-263.
8. CASEY, P. J. & GILMAN, A. G. (1988). G protein involvement in receptor-effector coupling. J. Biol. Chem. 263, 2577-2580.
9. CHILDERS, S. R., FLEMING, L. M., SELLEY, D. E., MCNUTT, R. W. & CHANG, K.-J. (1993). BW373U86: A nonpeptidic δ-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells. Mol. Pharmacol. 44, 827-834.
10. DE LEAN, A., STADEL, J. M. & LEFKOWITZ, R. J. (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255, 7108-7117.
11. EHLERT, F. J. & RATHBUN, B. E. (1990). Signaling through the muscarinic receptor-adenylate cyclase system of the heart is buffered against GTP over a range of concentrations. Mol. Pharmacol. 38, 148-158.
12. FRANKE, R. R., KÖNIG, B., SAKMAR, T. P., KHORANA, H. G. & HOFMANN, K. P. (1990). Rhodopsin mutants that bind but fail to activate transducin. Science 250, 123-125.
13. 3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex. Eur. J. Pharmacol. 160, 117-124.
14. HOYER, D. & BODDEKE, H. W. G. M. (1993). Partial agonists, full agonists, antagonists: dilemmas of definition. Trends Pharmacol. 14, 270-275.
15. KENAKIN, T. (1995a). Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity. Trends. Pharmacol. Sci. 16, 188-192.
16. KENAKIN, T. (1995b). Agonist-receptor efficacy II: agonist trafficking of receptor signals. Trends. Pharmacol. Sci. 16, 232-238.
17. KENAKIN, T. (1996). Receptor conformational induction versus selection: all part of the same energy landscape. Trends. Pharmacol. Sci. 17, 190-191.
18. LAMBRIGHT, D. G., SONDEK, J., BOHM, A., SKIBA, N. P., HAMM, H. E. & SIGLER, P. B. (1996). The 2.0 Å crystal structure of a heterotrimeric G protein. Nature 379, 311-319.
19. 35S]GTPγS binding mediated by human muscarinic m1-m4 receptors: antagonist studies. Br. J. Pharmacol. 109, 1120-1127.
20. LEFKOWITZ, R. J., COTECCHIA, S., SAMAMA, P. & COSTA, T. (1993). Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 141, 303-307.
21. MACKAY, D. (1990). Interpretation of relative potencies, relative efficacies and apparent affinity constants of agonist drugs estimated from concentration-response curves. J. theor. Biol. 142, 415-427.
22. 2 muscarinic receptors that are separately coupled to two biochemical effector systems. Mol. Pharmacol. 35, 39-47.
23. 1 muscarinic receptor and the hydrolysis of inositol lipids in transfected murine fibroblast cells (B82) expressing different receptor densities. J. Pharmacol. Exp. Ther. 251, 90-97.
24. MIGEON, J. C. & NATHANSON, N. M. (1994). Differential regulation of cAMP-mediated gene transcription by m1 and m4 muscarinic acetylcholine receptors. J. Biol. Chem. 269, 9767-9773.
25. oα subunits. J. Biol. Chem. 270, 16070-16074.
26. 2-adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex. Biochemistry 27, 2374-2384.
27. ONARAN, H. O., COSTA, T. & RODBARD, D. (1993). βγ subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits. Mol. Pharmacol. 43, 245-256.
28. 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc. Natl. Acad. Sci. U.S.A. 91, 2699-2702.
29. 2-adrenergic receptor. J. Biol. Chem. 268, 4625-4636.
30. SEGEL, I. H. (1975). Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-state Enzyme Systems pp. 793-795. New York: Wiley & Sons.
31. 2-adrenergic receptor. Mol. Pharmacol. 34, 814-822.
32. VAN KOPPEN, C. J., SELL, A., LENZ, W. & JAKOBS, K. H. (1994). Deletion analysis of the m4 muscarinic acetylcholine receptor. Eur. J. Biochem. 222, 525-531.
33. 1 receptors: evidences for multiple receptor states. Mol. Pharmacol. (in press).
34. VOGEL, W. K., MOSSER, V. A., BULSECO, D. A. & SCHIMERLIK, M. I. (1995). Porcine m2 muscarinic acetylcholine receptor-effector coupling in Chinese hamster ovary cells. J. Biol. Chem. 270, 15485-15493.
35. 1γ2. Cell 83, 1047-1058.
36. WEISS, J. M., MORGAN, P. H., LUTZ, M. W. & KENAKIN, T. P. (1996a). The cubic ternary complex receptor-occupancy model. I. Model description. J. theor. Biol. 178, 151-167.
37. WEISS, J. M., MORGAN, P. H., LUTZ, M. W. & KENAKIN, T. P. (1996b). The cubic ternary complex receptor-occupancy model. II. Understanding apparent affinity. J. theor. Biol. 178, 169-182.
38. WEISS, J. M., MORGAN, P. H., LUTZ, M. W. & KENAKIN, T. P. (1996c). The cubic ternary complex receptor-occupancy model. III. Resurrecting efficacy. J. theor. Biol. 181, 381-397.
39. WIELAND, T. & JAKOBS, K. H. (1994). Measurement of receptor-stimulated guanosine 5′0-(γ-Thio)triphosphate binding by G proteins. Meth. Enzymol. 237, 3-15.